{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:10:49Z","timestamp":1760825449935,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jocn.2022.01.025","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T07:10:20Z","timestamp":1643958620000},"page":"11-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pravastatin may improve neurological outcome following low-grade aneurysmal subarachnoid hemorrhage"],"prefix":"10.1016","volume":"98","author":[{"given":"T.","family":"Mazard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ritzenthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Dailler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocn.2022.01.025_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/2152-7806.198738","article-title":"Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives","volume":"8","author":"Grasso","year":"2017","journal-title":"Surg Neurol Int"},{"issue":"6","key":"10.1016\/j.jocn.2022.01.025_b0010","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.jocn.2022.01.025_b0015","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1161\/STROKEAHA.117.017777","article-title":"Predictors of outcome in aneurysmal subarachnoid hemorrhage patients: observations from a multicenter data set","volume":"48","author":"Galea","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2022.01.025_b0020","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1016\/j.wneu.2018.07.196","article-title":"Risk factors for mild cognitive impairment in patients with aneurysmal subarachnoid hemorrhage treated with endovascular coiling","volume":"119","author":"Shen","year":"2018","journal-title":"World Neurosurgery"},{"issue":"6","key":"10.1016\/j.jocn.2022.01.025_b0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.anrea.2016.08.003","article-title":"D\u00e9ficit isch\u00e9mique secondaire et h\u00e9morragie m\u00e9ning\u00e9e, un nouveau paradigme","volume":"2","author":"Mounier","year":"2016","journal-title":"Anesth\u00e9sie & R\u00e9animation"},{"issue":"1","key":"10.1016\/j.jocn.2022.01.025_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","article-title":"Delayed neurological deterioration after subarachnoid haemorrhage","volume":"10","author":"Macdonald","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2022.01.025_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pharmthera.2004.10.002","article-title":"Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment","volume":"105","author":"Pluta","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jocn.2022.01.025_b0040","unstructured":"Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH 2016:16."},{"issue":"6674","key":"10.1016\/j.jocn.2022.01.025_b0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","article-title":"Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial","volume":"298","author":"Pickard","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2022.01.025_b0050","doi-asserted-by":"crossref","unstructured":"Dorhout Mees SM, Rinkel GJE, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007:CD000277. 10.1002\/14651858.CD000277.pub3.","DOI":"10.1002\/14651858.CD000277.pub3"},{"issue":"5","key":"10.1016\/j.jocn.2022.01.025_b0055","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month","volume":"95","author":"O'Driscoll","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jocn.2022.01.025_b0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.wneu.2010.03.032","article-title":"Statins: a potential therapeutic addition to treatment for aneurysmal subarachnoid hemorrhage?","volume":"73","author":"Sabri","year":"2010","journal-title":"World Neurosurg"},{"issue":"25","key":"10.1016\/j.jocn.2022.01.025_b0065","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1161\/01.CIR.102.25.3104","article-title":"Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription","volume":"102","author":"Laufs","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jocn.2022.01.025_b0070","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1253\/circj.CJ-15-0443","article-title":"Effects of the Rho-Kinase Inhibitor, Fasudil, on Pulmonary Hypertension","volume":"79","author":"Odagiri","year":"2015","journal-title":"Circulation J"},{"key":"10.1016\/j.jocn.2022.01.025_b0075","doi-asserted-by":"crossref","unstructured":"McNeish AJ, Jimenez-Altayo F, Cottrell GS, Garland CJ. Statins and Selective Inhibition of Rho Kinase Protect Small Conductance Calcium-Activated Potassium Channel Function (KCa2.3) in Cerebral Arteries. PLOS ONE 2012;7:e46735. 10.1371\/journal.pone.0046735.","DOI":"10.1371\/journal.pone.0046735"},{"issue":"10","key":"10.1016\/j.jocn.2022.01.025_b0080","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jocn.2022.01.025_b0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrneurol.2016.89","article-title":"The Glasgow outcome scale \u2014 40 years of application and refinement","volume":"12","author":"McMillan","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2022.01.025_b0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2307\/2533160","article-title":"Matching using estimated propensity scores: relating theory to practice","volume":"52","author":"Rubin","year":"1996","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.jocn.2022.01.025_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-10-47","article-title":"Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?","volume":"10","author":"Arboix","year":"2010","journal-title":"BMC Neurol"},{"issue":"12","key":"10.1016\/j.jocn.2022.01.025_b0100","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1212\/WNL.0000000000002493","article-title":"Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke","volume":"86","author":"Tsivgoulis","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2022.01.025_b0105","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1161\/STROKEAHA.109.556332","article-title":"Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jocn.2022.01.025_b0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1227\/01.neu.0000316009.19012.e3","article-title":"Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage","volume":"62","author":"Kramer","year":"2008","journal-title":"Neurosurgery"},{"issue":"7","key":"10.1016\/j.jocn.2022.01.025_b0115","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1474-4422(14)70084-5","article-title":"Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial","volume":"13","author":"Kirkpatrick","year":"2014","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2022.01.025_b0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/EJA.0000000000000307","article-title":"The effect of an anaesthetic patient information video on perioperative anxiety: A randomised study","volume":"33","author":"Lin","year":"2016","journal-title":"Eur J Anaesthesiol"},{"issue":"6","key":"10.1016\/j.jocn.2022.01.025_b0125","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1177\/0300060517713803","article-title":"Clinical evidence of efficacy of simvastatin for aneurysmal subarachnoid hemorrhage","volume":"45","author":"Lin","year":"2017","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jocn.2022.01.025_b0130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.wneu.2017.01.125","article-title":"Cholesterol-reducing agents for treatment of aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"Akhigbe","year":"2017","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.jocn.2022.01.025_b0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3171\/2016.5.JNS152900","article-title":"Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"127","author":"Shen","year":"2017","journal-title":"J Neurosurg"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:28:19Z","timestamp":1760822899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":27,"alternative-id":["S0967586822000327"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.01.025","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pravastatin may improve neurological outcome following low-grade aneurysmal subarachnoid hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}